Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...
This is to honor her five-year-old son, who has Angelman Syndrome, a rare neuro-genetic disorder that affects one in 15,000. According to the Mayo Clinic, Angelman Syndrome causes delayed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback